Oracle Investment Management »

Cava Group Ord shares owned by Oracle Investment Management

Quarter-by-quarter ownership of Cava Group Ord (CAVA) shares owned by Oracle Investment Management from 13F filings

Historical chart of Oracle Investment Management investment in Cava Group Ord

Tip: Access up to 7 years of quarterly data

All positions including Cava Group Ord held by Oracle Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cava Group Ord by Oracle Investment Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.7M 19k 92.75
2024-03-31 $1.2M 18k 70.05

More positions owned by Oracle Investment Management

Genedx Holdings Corp Com Cl A (WGS)
Biohaven (BHVN)
Ardelyx (ARDX)
Springworks Therapeutics (SWTX)
Biohaven Call Call Option
Quidel Corp (QDEL)
Eyepoint Pharmaceuticals Call Call Option
Forian Ord (FORA)
BioCryst Pharmaceuticals (BCRX)
Phathom Pharmaceuticals (PHAT)
Eyepoint Pharmaceuticals Com New (EYPT)
Ardelyx Call Call Option
Myriad Genetics Call Call Option
Palantir Technologies Call Call Option
Cava Group Ord (CAVA)

View all positions for Oracle Investment Management

Top funds holding Cava Group Ord

Artal Group
Vanguard Group
D. E. Shaw & Co
Citadel Advisors
BlackRock
T. Rowe Price Associates
Susquehanna International
Two Sigma Investments
Two Sigma Advisers
Goodman & Company, Investment Counsel
Alliancebernstein
Lord, Abbett & Co
Voloridge Investment Management
Invesco
Morgan Stanley

View all funds holding Cava Group Ord